Using computational methods, they identified 2 promising drugs, Saikosaponin-F & Elbasvir, that can target alpha subunits. Elbasvir is an FDA-approved drug for Hepatitis C, it has already passed rigorous safety & efficacy tests, which could accelerate its repurposing for fighting tuberculosis.
(5/6)

🚦Updates to colour grades: glecaprevir/pibrentasvir and elbasvir/grazoprevir both downgraded from 🟧AMBER to 🟨YELLOW due to weak inhibition of CYP3A4

Given your comment, I'm almost certain the thing I'm thinking of is Elbasvir. The timing would been right. The prof would have made the comment around 2010 or 2011, and I would have seen the talk I'm thinking of in 2015, which tracks with Elbasvir's 2016 approval. I'm confusing aminals and acetals!

Data for #MRK 1 pill duo of PI #Grazoprevir and NS5A inh #Elbasvir in cirrhotics/nulls/ HIV-HCV/renal dz @ #Liver14
http://bit.ly/1Eumq0G

#MRK to present "ultra-short" C-SWIFT ph 2 data looking at 4 wk rx with #Grazoprevir/#Elbasvir+#Sovaldi @ #Liver14
http://bit.ly/1Eumq0G

Dr. Lawitz "#grazoprevir+#elbasvir +/- RBV for 12-18 wks yields 95% SVR12 in GT1 null responder cirrhotics. RBV may not be needed?" #liver14

Q2/15: prelim status of #HCV 'nuc wars' when ph 2 SVR12 from #MRK C-CREST Grazoprevir/Elbasvir+ MK-3682 and #ACHN ACH-3422+ACH-3102 expected

Merck Seeks #FDA Approval of #HCV combo #grazoprevir and #elbasvir http://www.aidsmeds.com/articles/grazoprevir_elbasvir_FDA_1667_27301.shtml#.VXdMdUitWiQ.twitter

PDUFA date for $MRK single tablet #grazoprevir & #elbasvir is 1/28/2016. Data for #HCV GT 1,4,6, #HIV & chronic kidney disease incl dialysis

Merck Announces FDA Acceptance of Grazoprevir/Elbasvir NDA in certain HCV Genotypes http://sco.lt/6g31rV

#Merck C-SURFER study of #HCV combo #Elbasvir & #Grazoprevir in advanced Kidney Disease now in The Lancet http://www.mercknewsroom.com/news-release/hepatitis-c-newsroom/results-mercks-phase-3-study-investigational-chronic-hepatitis-c-t

Dr. Terrault: #grazoprevir #elbasvir combo without RBV gives high #HCV cure in advanced kidney disease incl. dialysis #LiverLeader #Liver15

C-Edge co-star study of #grazoprevir #elbasvir in #HCV pts on opioid agonists: high adherence & 95% SVR12 in GT1,4-6 #Liver15 #LiverLeader

Dr. Jacobson: 12 wk #grazoprevir #elbasvir in cirrhotics for #HCV GT1,4,5,6 incl. coinfection & CKD cures 98% naives #Liver15 #LiverLeader

Dr. Sperl: #grazoprevir & #elbasvir is better than #sofosbuvir #peginterferon #ribavirin in GT1 and 4 patients given 12 weeks. #ILC2016

@AASLDtweets grazoprevir/elbasvir/sofosbuvir cures 96% TN & 94% TE cirrhotic GT3 #HCV. 100% completers cured #LiverMtg16

Retweeted CTAC (@CTAC_CAN):

New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw

Retweeted CTAC (@CTAC_CAN):

New HCV medication Elbasvir/Grazoprevir receives its Notice of Compliance from... http://fb.me/7Mac03Yjw